# Xeltis Hemodialysis Access Graft: aXess Pivotal Study

> **NCT05473299** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Xeltis** · enrollment: 120 (actual)

## Conditions studied

- End-stage Renal Disease

## Interventions

- **DEVICE:** Xeltis Hemodialysis Access (aXess) graft

## Key facts

- **NCT ID:** NCT05473299
- **Lead sponsor:** Xeltis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-04
- **Primary completion:** 2025-06-23
- **Final completion:** 2029-12-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05473299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05473299, "Xeltis Hemodialysis Access Graft: aXess Pivotal Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05473299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*